Nektar Therapeutics awarded $90M jury verdict against Eli Lilly over rezpegaldesleukin dispute

Nektar Therapeutics won a $90 million jury verdict finding Eli Lilly breached the implied covenant under their rezpegaldesleukin license agreement.Key Highlights:Original SEC Filing: NEKTAR THERAPEUTICS [ NKTR ] - 8-K - Sep. 25, 2026This is an AI-powered summary. It may contain inaccuracies. Consid…